Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Novozymes Breaks Ground on New China Manufacturing Facility

publication date: Apr 28, 2009

Novozymes, a Danish company that provides enzymes for industrial and consumer use, and also manufactures recombinant biopharma products and APIs, will spend $35-$50 million to build a new facility at its existing site in Tianjin, China. The new factory will produce Bacillus-based Hyaluronic Acid (bHA), which is used in medical devices, topical eye care treatments and drug delivery. More details..

Stock Symbol: (NASDAQ OMX Copenhagen A/S (NZYM B))



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital